Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 2226Sesión 2025-2026

An Act amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.

House Amendment A03890

H2226B2917A03890 MAB:AAS 06/23/26 #90 A03890AMENDMENTS TO HOUSE BILL NO. 2226Sponsor: REPRESENTATIVE WARRENPrinter's No. 2917Amend Bill, page 1, lines 1 through 19; pages 2 through 7, lines 1 through 30; page 8, lines 1 through 7; by striking out all of said lines on said pages and inserting Amending Title 40 (Insurance) of the Pennsylvania Consolidated Statutes, providing for prescription drug cost credits in health insurance; and imposing penalties.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Title 40 of the Pennsylvania Consolidated Statutes is amended by adding a chapter to read:CHAPTER 52FAIR CO-PAY ASSISTANCE CREDITSSubchapterA. Preliminary ProvisionsB. Fair Co-Pay Assistance CreditsC. Miscellaneous ProvisionsSUBCHAPTER APRELIMINARY PROVISIONSSec.5201. Scope of chapter.5202. Definitions.§ 5201. Scope of chapter.This chapter relates to the crediting of co-pay assistance provided for prescription drugs toward health benefit plan cost-sharing. This chapter does not apply to a self-insured health benefit plan subject to 29 U.S.C. Ch. 18 (relating to Employee Retirement Income Security Program) or exempted from 29 U.S.C. Ch. 18.§ 5202. Definitions.The following words and phrases when used in this chapter shall have the meanings given to them in this section unless the context clearly indicates otherwise:"Commissioner." The Insurance Commissioner of the Commonwealth."Cost-sharing." Means as follows:(1) The share of the health care costs covered by a health benefit plan that a covered person pays out-of-pocket.2026/90MAB/HB2226A03890 - 1 -12345678910111213141516171819202122232425262728293031323334353637 (2) The term includes deductibles, coinsurance, copayments and similar charges.(3) The term does not include premiums, balance billed amounts from an out-of-network health care provider or the cost of noncovered services except as specified in this chapter."Covered person." A policyholder, subscriber or other individual who is entitled to receive health care services under a health benefit plan."Department." The Insurance Department of the Commonwealth."Drug manufacturer direct support." An amount a drug manufacturer pays in any manner toward reducing the cost-sharing incurred by a covered person for the purchase of a specific prescription drug."Generically equivalent drug." The term shall have the meaning given to it in section 2 of the act of November 24, 1976 (P.L.1163, No.259), known as the Generic Equivalent Drug Law."Health benefit plan." The term shall have the meaning given to it in the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Benefit Reform Act."Health care provider." A person who is licensed, certified or otherwise regulated to provide health care services under the laws of this Commonwealth."Health insurer client." The term shall have the meaning given to it in the Pharmacy Benefit Reform Act."Health insurer." The term shall have the meaning given to it in the Pharmacy Benefit Reform Act."Interchangeable biological product." The term shall have the meaning given to it in section 2 of the Generic Equivalent Drug Law."Out-of-network health care provider." A health care provider who does not contract with a health insurer client to provide health care services to a covered person under a health benefit plan."Pharmacy benefits manager." The term shall have the meaning given to it in the Pharmacy Benefit Reform Act."Prescription drug." The term shall include a drug, a generically equivalent drug, a biological product, and an interchangeable biological product, as those terms are defined in section 2 of the Generic Equivalent Drug Law, that is prescribed by a health care provider. The term shall also include insulin, insulin syringes and insulin needles."Prescription drug coverage administrator." A health benefit plan, health insurer, or a pharmacy benefits manager that administers pharmacy benefits for a health insurer client.SUBCHAPTER BFAIR CO-PAY ASSISTANCE CREDITSSec.5211. Cost-sharing credit.5212. Prohibited crediting.5213. Limitations.2026/90MAB/HB2226A03890 - 2 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051 5214. Exempted arrangements.§ 5211. Cost-sharing credit.Except as provided in section 5212 (relating to prohibited crediting) or exempted by section 5214 (relating to exempted arrangements), for each fill of a prescription drug, a prescription drug coverage administrator shall reduce the cost-sharing incurred by a covered person or credit toward the covered person's in-network out-of-pocket maximum and other cost-sharing requirements any amount paid on behalf of the covered person by another person for the prescription drug, including drug manufacturer direct support, provided that all of the following apply:(1) The prescription drug is on the covered person's health insurance policy formulary.(2) The prescription drug either:(i) Does not have a generic equivalent drug or interchangeable biological product.(ii) Does have a generic equivalent drug or interchangeable biological product but the covered person has obtained access to the prescription drug through any of the following:(A) Prior authorization.(B) A step therapy protocol.(C) The health insurer's exceptions and appeals process.§ 5212. Prohibited crediting.A prescription drug coverage administrator may not credit drug manufacturer direct support toward the covered person's in-network out-of-pocket maximum and other cost-sharing requirements if the support is not both:(1) Available to each covered person of every health insurance policy issued or renewed in this Commonwealth.(2) Available in the same monetary amount for each initial fill and each refill throughout the plan year of the covered person's health insurance policy.§ 5213. Limitations.A prescription drug coverage administrator may not credit drug manufacturer direct support toward the covered person's in-network out-of-pocket maximum and other cost-sharing requirements if either of the following applies:(1) The covered person's health insurance policy is a high deductible health plan under 26 U.S.C. § 223(c) (relating to health savings accounts) offered in conjunction with a health savings account, the drug manufacturer direct support is used towards the purchase of a prescription drug other than as permitted on a pre-deductible basis under 26 U.S.C. § 223(c), and the drug manufacturer direct support is used during any portion of the plan year during which the deductible of the health insurance policy is not satisfied.(2) The credit is not applied to a health insurance policy which is in whole or in part determined to be a 2026/90MAB/HB2226A03890 - 3 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051 Federal health care program.§ 5214. Exempted arrangements.(a) Agreement.--A prescription drug coverage administrator shall be exempt from the requirements of section 5211 (relating to cost-sharing credit) if it enters into an agreement with an entity that provides drug manufacturer direct support, pursuant to which the prescription drug coverage administrator accepts payments on behalf of covered persons, provided that the agreement complies with all provisions of this chapter.(b) Voluntary program.--A prescription drug coverage administrator's program shall be exempt from the requirements of this chapter if it is a voluntary program offered to a covered person under a health benefit plan in which the value of a pharmaceutical manufacturer's assistance program is applied to reduce a covered person's out-of-pocket costs to a fixed monthly amount for the benefit year for a specific prescription and any actual cost the covered person pays while in the program is applied to the covered person's applicable out-of-pocket maximum responsibility.SUBCHAPTER CMISCELLANEOUS PROVISIONSSec.5221. Protections.5222. Regulations.5223. Enforcement.§ 5221. Protections.Nothing in this chapter shall require a health benefit plan to credit co-pay assistance for a prescription drug in derogation of a policyholder's constitutional protections of religious freedom under the act of December 9, 2002 (P.L.1701, No.214), known as the Religious Freedom Protection Act, or 42 U.S.C. Ch. 21B (relating to religious freedom restoration).§ 5222. Regulations.The department may promulgate regulations as necessary and appropriate to carry out the provisions of this chapter.§ 5223. Enforcement.(a) Penalties.--After satisfactory evidence of the violation of this chapter by a prescription drug coverage administrator, one or more of the following penalties may be imposed at the commissioner's discretion:(1) Suspension or revocation of the offending entity's license or registration.(2) Refusal, for a period not to exceed one year, to issue a new license or registration to the offending entity.(3) A fine of not more than $5,000 for each violation of this chapter.(4) A fine of not more than $10,000 for each willful violation of this chapter.(b) Limitation.--Fines imposed against an entity under this section may not exceed $500,000 in the aggregate during a single calendar year.2026/90MAB/HB2226A03890 - 4 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051 (c) Additional remedies.--The enforcement remedies imposed under this section are in addition to any other remedies or penalties that may be imposed under any other applicable law of this Commonwealth, including:(1) The act of July 22, 1974 (P.L.589, No.205), known as the Unfair Insurance Practices Act. A violation of this chapter shall be deemed to be an unfair method of competition and an unfair or deceptive act or practice under the Unfair Insurance Practices Act.(2) The act of December 18, 1996 (P.L.1066, No.159), known as the Accident and Health Filing Reform Act.(3) The act of June 25, 1997 (P.L.295, No.29), known as the Pennsylvania Health Care Insurance Portability Act.(4) The act of November 21, 2016 (P.L.1318, No.169), as amended, known as the Pharmacy Benefit Reform Act.(d) Administrative procedure.--The administrative provisions of this chapter shall be subject to 2 Pa.C.S. Ch. 5 Subch. A (relating to practice and procedure of Commonwealth agencies). A party against whom penalties are assessed in an administrative action may appeal to Commonwealth Court as provided in 2 Pa.C.S. Ch. 7 Subch. A (relating to judicial review of Commonwealth agency action).Section 2. The following shall apply:(1) For health benefit plans for which either rates or forms are required to be filed with the department, this chapter shall apply to any policy for which a form or rate is first filed on or after the effective date of this subparagraph.(2) For health benefit plans for which neither rates nor forms are required to be filed with the department, this chapter shall apply to any policy issued or renewed on or after 180 days after the effective date of this subparagraph.Section 3. This act shall take effect as follows:(1) Section 2 of this act and this section shall take effect immediately.(2) The remainder of this act shall take effect in 60 days.2026/90MAB/HB2226A03890 - 5 -12345678910111213141516171819202122232425262728293031323334353637

Texto oficial de la Legislatura de Pennsylvania. El formato se adaptó para leerlo en Ratifi.